CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2024	$ 407,976	$ 7	$ 951,519	$ 674	$ (544,224)
Beginning Balance, Shares at Dec. 31, 2024		70,645,139
Issuance of common stock upon vesting of restricted stock units, Shares		312,415
Share-based compensation expense	2,834		2,834
Net unrealized loss on investments	(22)			(22)
Net loss	(31,983)				(31,983)
Ending Balance at Mar. 31, 2025	378,805	$ 7	954,353	652	(576,207)
Ending Balance, Shares at Mar. 31, 2025		70,957,554
Beginning Balance at Dec. 31, 2025	312,325	$ 7	960,219	407	(648,308)
Beginning Balance, Shares at Dec. 31, 2025		71,078,531
Issuance of common stock upon exercise of stock options	6		6
Issuance of common stock upon exercise of stock options, Shares		3,719
Issuance of common stock upon vesting of restricted stock units, Shares		208,240
Share-based compensation expense	1,898		1,898
Net unrealized loss on investments	(537)			(537)
Net loss	(27,832)				(27,832)
Ending Balance at Mar. 31, 2026	$ 285,860	$ 7	$ 962,123	$ (130)	$ (676,140)
Ending Balance, Shares at Mar. 31, 2026		71,290,490